What is the effect of Metformin for APOE4 carriers?
Phoenix has measured Metformin against 4 exact outcomes for APOE4 carriers. Member #2351C3's Glucose moved from 114 to 88 mg/dL in 718 days. Member #15000A lowered fasting insulin from 12.6 to 6.5 uIU/mL in 162 days on metformin and tirzepatide, both undated. Member #2351C3's LDL cholesterol moved from 83 to 59 mg/dL in 881 days. Member #2351C3's Triglycerides moved from 101 to 62 mg/dL in 795 days.